Today's Adjuvant Therapy in Breast Cancer: Who Should Receive What?
Breast cancer remains a major public health problem. Prospective randomized trials comparing therapies are essential to improve current therapy but, for those women unable or unwilling to participate in clinical trials, treatment plans are needed. Treatment recommendations can be based on available information from individual trials and from a large collaborative overview. This information will be reviewed with treatment recommendations presented for subpopulations of breast cancer patients.
Roberge
AE
Division of Hematology/Oncology, New England Medical Center, Boston, Massachusetts 02111, USA.
Erban
JK